4B: Fast Tracks and Fault Lines: Reassessing FDA’s Market Pathways and Review
4B: Fast Tracks and Fault Lines: Reassessing FDA’s Market Pathways and Review
June 4, 2026 01:45 PM 03:15 PM Room 341
- Holly Fernandez Lynch, Perelman School of Medicine, University of Pennsylvania, FDA’s Accelerated Approval Pathway as a One-Way Ratchet
- Walter G. Johnson, Stanford Law School, Comparing Expedited Review Pathways at the FDA
- Lauren Walsh, University of Pennsylvania, Artificial Intelligence in Drug Development — Balancing Innovation with Safety and Effectiveness
- Ryan Knox, DePaul University College of Law, Withdrawal of FDA Approval
- Rebekah Ninan and Matthew Clauss, Uncertain Definition, Uncertain Outcomes: Searching for Vaccines in the Law